Uncategorized
STAT+: Sanofi MS drug gets positive review in Europe following FDA
Regeneron is in the headlines again: It cut a pricing deal with the Trump administration and won approval for a hearing loss gene therapy. Also, Medicare and the FDA are getting creative with their efforts to speed medical device coverage.
And since it’s totally worth it, sign up for STAT+ between now and Saturday and you’ll get 60% off your first year.
MS drug rejected by FDA gets warmer reception in Europe
From STAT’s Andrew Joseph: A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer audience in European regulators, who recommended today that the medicine should be approved.
Regeneron is in the headlines again: It cut a pricing deal with the Trump administration and won approval for a hearing loss gene therapy. Also, Medicare and the FDA are getting creative with their efforts to speed medical device coverage.
And since it’s totally worth it, sign up for STAT+ between now and Saturday and you’ll get 60% off your first year.
MS drug rejected by FDA gets warmer reception in Europe
From STAT’s Andrew Joseph: A multiple sclerosis drug from Sanofi that was rejected late last year by the FDA found a warmer audience in European regulators, who recommended today that the medicine should be approved.
NEW YORK — No quick dispatching of disease investigators. No televised news conference to inform the public. No timely health alerts to doctors.
In the midst of a hantavirus outbreak that involves Americans and is making headlines around the world, the U.S. government’s top public health agency, the Centers for Disease Control and Prevention, has been uncharacteristically missing in action, according to a number of experts.
Uncategorized
Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national news
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Will Flanary, aka Dr. Glaucomflecken. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.
Torie Bosch: Will Flanary is better known as Dr. Glaucomflecken. He is social media’s most famous comedian slash doctor, and he’s not afraid of punching up.
Below is a lightly edited, AI-generated transcript of the “First Opinion Podcast” interview with Will Flanary, aka Dr. Glaucomflecken. Be sure to sign up for the weekly “First Opinion Podcast” on Apple Podcasts, Spotify, or wherever you get your podcasts. Get alerts about each new episode by signing up for the “First Opinion Podcast” newsletter. And don’t forget to sign up for the First Opinion newsletter, delivered every Sunday.
Torie Bosch: Will Flanary is better known as Dr. Glaucomflecken. He is social media’s most famous comedian slash doctor, and he’s not afraid of punching up.
Uncategorized
Biotech’s new company model; The super poop behind a startup launch; and more
Biotech’s new company model; The super poop behind a startup launch; and more
Welcome back to another edition of Endpoints Weekly! Earnings season is in full swing, but we had plenty of original reporting and exclusives you won’t find anywhere else this week. Chief among them: Andrew Dunn’s … Read More
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
Experts wonder ‘Where is the CDC?’ as hantavirus outbreak unfolds
Opinion: Dr. Glaucomflecken wants the corporatization of medicine to be national news
Biotech’s new company model; The super poop behind a startup launch; and more
New Hepta blood test could predict GLP-1 response
Spain readies for evacuations as a hantavirus-hit cruise ship heads for the Canary Islands
STAT+: Roche to buy PathAI for $750 million
Illinois’ financial crisis could bring the state to a halt
The final 6 ‘Game of Thrones’ episodes might feel like a full season
New Season 8 Walking Dead trailer flashes forward in time
Mod turns ‘Counter-Strike’ into a ‘Tekken’ clone with fighting chickens
Meet Superman’s grandfather in new trailer for Krypton
Disney’s live-action Aladdin finally finds its stars
-
Uncategorized9 years agoThese ’90s fashion trends are making a comeback in 2017
-
Uncategorized9 years ago
According to Dior Couture, this taboo fashion accessory is back
-
Contributors9 years ago
The final 6 ‘Game of Thrones’ episodes might feel like a full season
-
Uncategorized9 years ago
Uber and Lyft are finally available in all of New York State
-
Uncategorized9 years ago
Phillies’ Aaron Altherr makes mind-boggling barehanded play
-
Uncategorized9 years ago
The old and New Edition cast comes together to perform
-
Uncategorized9 years ago
Steph Curry finally got the contract he deserves from the Warriors
-
Uncategorized9 years ago
Disney’s live-action Aladdin finally finds its stars